Mumbai: On November 08, 2012, Sun Pharma will announce results for the second
quarter & half year ending September 30, 2012 . These results will also be available on the Company website, www.sunpharma.com.
Earnings call (10.00 am IST, November 09, 2012)
The Company will conduct an hour long call at 10 am IST on November 09, 2012 where senior management will discuss the Company's performance and answer questions from participants. To participate in this conference call, please dial the numbers provided below five to ten minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call. You can also hear the call via an audio webcast, details of which will be announced later on the Company website, www.sunpharma.com. A transcript of this conference call will also be available on the website.
Nova IVI Fertility Introduces Delhi’s First IVF Center with Embryoscope Facility Features live updates,...
New Delhi, Delhi, India, Thursday, December 13, 2012 - (Business Wire India)
Nova IVI Fertility, a division of Nova Medical Centers Pvt Ltd, India's leading short stay surgical company announces the launch of New Delhi's first of its kind IVF center with embryoscope facility, a technology to monitor growth of embryos with real time videos and live updates. Representing a world-class facility and spread across 12,500 sq feet, the hospital is located in the heart of the city and accessible to all patients. Nova IVI Fertility's other centers are in Ahmedabad, Bangalore, Kolkata and Mumbai with centers in Chennai and other cities to open soon.
GVK Biosciences and Onconova Therapeutics Establish Novel Joint Development Partnership to Advance New Drugs...
Hyderabad, Andhra Pradesh, India and Newtown, PA, United States, Wednesday, January 09, 2013 -- (Business Wire India) -- GVK BIO, Asia's leading Contract Research and Development organization and Onconova Therapeutics, a U.S. based biopharmaceutical company primarily focused on discovery and development of novel small molecules for Oncology, today announced that they have entered into a novel joint partnership to develop new drugs for Cancer.